|
gptkbp:instance_of
|
gptkb:Clinical_Trials
|
|
gptkbp:aims_to
|
reduce bleeding complications
|
|
gptkbp:analyzes
|
safety and efficacy
|
|
gptkbp:case_analysis
|
clinical effectiveness
|
|
gptkbp:completed
|
gptkb:2011
|
|
gptkbp:conducted
|
multiple centers
|
|
gptkbp:contributes_to
|
cardiology research
|
|
gptkbp:critical_analysis
|
treatment methodologies
|
|
gptkbp:examines
|
long-term effects of treatment
|
|
gptkbp:focuses_on
|
gptkb:acute_myocardial_infarction
|
|
gptkbp:has_a_focus_on
|
clinical pharmacology studies
|
|
gptkbp:has_a_follow-up_period_of
|
30 days
|
|
gptkbp:has_been_used_to_train
|
gptkb:healthcare_professionals
|
|
gptkbp:has_implications_for
|
treatment guidelines
|
|
gptkbp:has_influenced
|
clinical practice
|
|
gptkbp:has_led_to
|
further research initiatives
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
The HORIZONS-AMI Trial
|
|
gptkbp:includes
|
over 3600 participants
|
|
gptkbp:involves
|
patients with ST-elevation myocardial infarction
|
|
gptkbp:is_a_foundation_for
|
subsequent research projects
|
|
gptkbp:is_a_key_study_for
|
cardiovascular interventions
|
|
gptkbp:is_a_landmark_study_in
|
cardiovascular medicine
|
|
gptkbp:is_a_multicenter_trial_involving
|
various hospitals
|
|
gptkbp:is_a_pivotal_trial_in
|
the field of cardiology
|
|
gptkbp:is_a_reference_for
|
future clinical trials
clinical decision-making.
|
|
gptkbp:is_a_source_of
|
clinical evidence
|
|
gptkbp:is_a_subject_of
|
systematic reviews
medical researchers
medical literature reviews
|
|
gptkbp:is_analyzed_in
|
cost-effectiveness
|
|
gptkbp:is_associated_with
|
improved patient outcomes
reduced mortality rates
|
|
gptkbp:is_cited_in
|
numerous medical publications
|
|
gptkbp:is_compared_to
|
bivalirudin and heparin
|
|
gptkbp:is_designed_to
|
improve treatment protocols
|
|
gptkbp:is_discussed_in
|
medical conferences
|
|
gptkbp:is_funded_by
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:is_influential_in
|
medical education
|
|
gptkbp:is_led_by
|
gptkb:Dr._William_S._Weintraub
|
|
gptkbp:is_part_of
|
clinical research on anticoagulants
the ACC/ AHA guidelines
the evidence-based medicine movement
|
|
gptkbp:is_part_of_a_series_of_studies_on
|
acute coronary syndromes
|
|
gptkbp:is_recognized_by
|
medical associations
|
|
gptkbp:is_referenced_in
|
gptkb:guidelines
|
|
gptkbp:is_relevant_to
|
interventional cardiology
emergency response teams
|
|
gptkbp:is_significant_for
|
emergency medicine
|
|
gptkbp:key
|
cardiovascular risk assessment
|
|
gptkbp:measures
|
major adverse cardiovascular events
|
|
gptkbp:model
|
clinical trial design
|
|
gptkbp:notable_contributor
|
public health knowledge
|
|
gptkbp:performance
|
new anticoagulant studies
|
|
gptkbp:provides_information_on
|
healthcare policy decisions
|
|
gptkbp:published_in
|
gptkb:The_New_England_Journal_of_Medicine
|
|
gptkbp:registration
|
gptkb:Clinical_Trials.gov
|
|
gptkbp:results_indicate
|
bivalirudin is effective
|
|
gptkbp:sponsored_by
|
gptkb:Mount_Sinai_School_of_Medicine
|
|
gptkbp:started_in
|
gptkb:2008
|
|
gptkbp:uses
|
randomized controlled methodology
|
|
gptkbp:utilizes
|
data analysis techniques
|
|
gptkbp:was_a_demonstration_of
|
anticoagulation strategies
|
|
gptkbp:bfsParent
|
gptkb:The_New_England_Journal_of_Medicine
|
|
gptkbp:bfsLayer
|
6
|